Barosense
Company

Last deal

$27M

Amount

Series D

Stage

24.08.2009

Date

4

all rounds

$50.6M

Total amount

General

About Company
BaroSense Inc. develops minimally invasive medical devices for obesity treatment.

Industry

Sector :

Subsector :

founded date

01.01.2001

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

Based in Redwood City, CA, BaroSense is a medical device company focused on creating safe and effective alternatives to surgical treatment for obesity. Their innovative procedures and devices offer a less invasive approach for individuals seeking to lose weight and improve their health. BaroSense aims to develop and commercialize novel anti-obesity products that address the leading healthcare problem in the United States today. Their flagship product is a trans-oral endoscopic restrictive implant system, providing a reversible and minimally invasive option for weight loss.
Contacts